Screener
Surgery Partners, Inc. SGRY Q2 2026 earnings
Reported August 10, 2026 · Before market open
Revenue$848.9MBeat by $18.9M
EPS$0.10Beat by $0.04
Revenue estimate$830.0M
EPS estimate$0.06
“We are pleased with our progress this quarter, which reflects disciplined execution against our key strategic priorities to support a return to growth and reinforces our conviction in our short stay surgical platform. The announcement of the pending Idaho Falls transaction was a key achievement and represents an important step forward in our portfolio optimization strategy, as we take decisive actions to improve our financial profile and sharpen our strategic focus. Looking ahead, we will capitalize on the structural tailwinds underpinning long-term ASC market growth, enhance operational efficiency, and thoughtfully deploy capital to deliver long-term value for our shareholders.”
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$854.8M
EPS estimate$0.10
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Surgery Partners, Inc. report Q2 2026 earnings?
- Surgery Partners, Inc. (SGRY) reported Q2 2026 earnings on August 10, 2026 before market open.
- What were Surgery Partners, Inc.'s Q2 2026 revenue and EPS?
- Surgery Partners, Inc. reported revenue of $848.9M and eps of $0.10 for Q2 2026.
- Did Surgery Partners, Inc. beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $830.0M by $18.9M. EPS beat the consensus estimate of $0.06 by $0.04.
- How did Surgery Partners, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 2.7% from $826.2M a year earlier and eps declined 41.2% from $0.17.
- Where can I find Surgery Partners, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001638833-26-000074) and the 10-Q periodic report (0001638833-26-000077) directly on SEC EDGAR. The filing index links above go to sec.gov.
